SP1 and hepatocellular carcinoma: Within HCC patient tissues, an inverse correlation between CD147 expression and methylation status has been reported, and a mechanism study with Aza revealed that promoter hypomethylation enhances CD147 expression by increasing Sp1 binding [63].